Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs MOREPEN LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA MOREPEN LABS PLETHICO PHARMA/
MOREPEN LABS
 
P/E (TTM) x -0.1 34.2 - View Chart
P/BV x 0.0 3.5 0.5% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 PLETHICO PHARMA   MOREPEN LABS
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
MOREPEN LABS
Mar-23
PLETHICO PHARMA/
MOREPEN LABS
5-Yr Chart
Click to enlarge
High Rs25455 463.5%   
Low Rs3124 132.1%   
Sales per share (Unadj.) Rs604.627.7 2,180.1%  
Earnings per share (Unadj.) Rs32.50.8 4,293.9%  
Cash flow per share (Unadj.) Rs51.31.3 3,940.1%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs473.714.7 3,216.0%  
Shares outstanding (eoy) m34.07511.17 6.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.21.4 16.7%   
Avg P/E ratio x4.451.8 8.5%  
P/CF ratio (eoy) x2.830.1 9.2%  
Price / Book Value ratio x0.32.7 11.3%  
Dividend payout %00-   
Avg Mkt Cap Rs m4,85920,051 24.2%   
No. of employees `000NANA-   
Total wages/salary Rs m1,5471,547 100.0%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m20,59814,175 145.3%  
Other income Rs m41961 684.0%   
Total revenues Rs m21,01714,237 147.6%   
Gross profit Rs m2,938795 369.4%  
Depreciation Rs m642279 230.0%   
Interest Rs m1,74720 8,816.9%   
Profit before tax Rs m968558 173.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-138171 -81.0%   
Profit after tax Rs m1,107387 286.2%  
Gross profit margin %14.35.6 254.2%  
Effective tax rate %-14.330.6 -46.6%   
Net profit margin %5.42.7 197.0%  
BALANCE SHEET DATA
Current assets Rs m18,8777,562 249.6%   
Current liabilities Rs m11,8963,212 370.4%   
Net working cap to sales %33.930.7 110.4%  
Current ratio x1.62.4 67.4%  
Inventory Days Days7818 431.3%  
Debtors Days Days198678 29.2%  
Net fixed assets Rs m14,2693,543 402.7%   
Share capital Rs m3411,022 33.3%   
"Free" reserves Rs m15,7986,507 242.8%   
Net worth Rs m16,1397,529 214.4%   
Long term debt Rs m4,7069 50,382.8%   
Total assets Rs m33,14611,105 298.5%  
Interest coverage x1.629.1 5.3%   
Debt to equity ratio x0.30 23,504.9%  
Sales to assets ratio x0.61.3 48.7%   
Return on assets %8.63.7 235.1%  
Return on equity %6.95.1 133.5%  
Return on capital %13.07.7 170.1%  
Exports to sales %21.439.9 53.6%   
Imports to sales %15.230.5 49.9%   
Exports (fob) Rs m4,4025,657 77.8%   
Imports (cif) Rs m3,1364,324 72.5%   
Fx inflow Rs m4,4025,657 77.8%   
Fx outflow Rs m3,1844,444 71.7%   
Net fx Rs m1,2191,213 100.4%   
CASH FLOW
From Operations Rs m2,437-912 -267.3%  
From Investments Rs m-6,265-465 1,347.0%  
From Financial Activity Rs m2,4901,435 173.5%  
Net Cashflow Rs m2459 41.8%  

Share Holding

Indian Promoters % 57.8 38.2 151.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 19.4 4.0 484.0%  
FIIs % 2.7 1.9 145.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 42.3 61.8 68.4%  
Shareholders   16,430 336,019 4.9%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on PLETHICO PHARMA vs MOREPEN LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

PLETHICO PHARMA vs MOREPEN LABS Share Price Performance

Period PLETHICO PHARMA MOREPEN LABS S&P BSE HEALTHCARE
1-Day -4.91% 1.76% 0.45%
1-Month -1.24% 21.24% 2.55%
1-Year -70.21% 86.88% 56.14%
3-Year CAGR -66.86% -0.01% 15.22%
5-Year CAGR -51.20% 24.56% 19.63%

* Compound Annual Growth Rate

Here are more details on the PLETHICO PHARMA share price and the MOREPEN LABS share price.

Moving on to shareholding structures...

The promoters of PLETHICO PHARMA hold a 57.8% stake in the company. In case of MOREPEN LABS the stake stands at 38.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of PLETHICO PHARMA and the shareholding pattern of MOREPEN LABS.

Finally, a word on dividends...

In the most recent financial year, PLETHICO PHARMA paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.

MOREPEN LABS paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of PLETHICO PHARMA, and the dividend history of MOREPEN LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7% Sensex Today Tanks 609 Points | Auto Stocks Drag | Bajaj Finance, L&T Technology Sink 7%(Closing)

After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.